California-based Rune Labs, a precision neurology software and data platform company, is partnering with BlueRock Therapeutics, a clinical-stage biopharmaceutical company and subsidiary of Bayer AG, to aid in studying Parkinson's disease.
BlueRock will utilize Rune Labs' clinical development platform, StriveStudy, for clinical trial enrollment, real-world evidence data generation and monitoring...
Bayer launches telehealth platform for endometriosis in Malaysia
Pharmaceutical firm Bayer has partnered with digital health company DoctorOnCall and the Endometriosis Association of Malaysia (MyEndosis) to launch a telehealth platform dedicated to endometriosis.
Endometriosis, a condition that affects one in 10 women worldwide, occurs when the endometrium grows outside the womb in other tissues...
Germany’s Bayer has launched Saudi Arabia’s first “digital hub” to improve management of pulmonary hypertension (PH), it has announced.
The AAN Digital Hub – reportedly designed to address gaps in diagnosis and treatment of the condition during the COVID-19 pandemic – focuses on facilitating virtual referrals for patients, as well as enabling knowledge exchange between primary physicians and...
The partnership will help visitors to Bayer websites for Aspirin, Aleve, Midol, Cenesten and Iberogast to access Ada’s intelligent symptom assessment platform.
Using an AI-based health assessment platform, Berlin-based Ada Health assists users in identifying the correct care, based on their individual requirements, risk factors and symptoms.
The free app provides guidance via an AI chatbot which...
A total of nine companies have been accepted into Bayer’s Digital Health Partnership Program, as annouced on the EU Startups website recently.
In 2021, the pharmaceutical company was specifically looking for young companies with expertise in the focus areas of mental health, cardiometabolic and reneal diseases, radiology and women’s health across Europe.
WHAT’S THE IMPACT
The finalists were...
Digital chronic condition management company One Drop on Wednesday launched its newest product aimed at cardiovascular disease prevention.
The tool — the first to come out of a partnership between the digital health company and pharma giant Bayer — allows users to track blood pressure and weight in the app using connected devices, log meals, receive coaching from registered nurses, learn AI-...
Bayer Middle East has introduced its Alleye Home Monitoring Sponsorship Programme to the Egyptian healthcare sector, it has been confirmed. The global pharma giant is reportedly working with some of the country’s top-rated eye hospitals to “support Egypt’s ophthalmologists in the new era” of virtual care for patients with either Diabetic Macular Edema [DME] – a complication of diabetic...
111 to build a disease management platform with Bayer
Chinese healthcare platform 111 has expanded its existing partnership with global drug maker Bayer Healthcare Co.
The two companies first entered into a strategic partnership last year in September to market innovative drugs and healthcare products for chronic disease management. A digital platform was also built to provide online pharmacist...
The life science world has continued to deepen its interest in the digital space. While the mainstream life science news of the year was research on the coronavirus vaccine, when it came to digital the industries efforts were more varied. We saw new partnerships between pharma and digital health around topics such as respiration health, cardiovascular conditions and real-world data.
This year we...
Today One Drop announced a string of new deals with Bayer that could bring the digital diabetes-management company nearly $100 million in new funds.
The agreements include the closure of a Series C financing round led by the pharma giant, as well as $64 million in unspecified development commitments and potential commercial milestone payments.
Launched in late 2016, One Drop's wireless blood...
.jpeg?itok=HF3iI7dj "Person answering their front door and getting a delivery from another person")
